Packed Red Blood Cells for Anemia Management

Introduction to PRBCs

The American College of Physicians and other medical societies recommend PRBCs as the preferred blood product for transfusion to correct anemia in virtually all clinical scenarios, due to their higher concentration of red blood cells per unit volume 1, 2

PRBCs deliver a higher concentration of red blood cells per unit volume (hematocrit 50-80%) compared to whole blood, providing more efficient correction of oxygen-carrying capacity 1
Each 300 mL unit of PRBCs contains 42.5-80 g of hemoglobin and typically raises hemoglobin by approximately 1 g/dL in normal-sized adults without ongoing blood loss 1, 3
This concentrated formulation allows for more precise hemoglobin correction while minimizing volume overload, a critical consideration in patients with cardiovascular or renal disease 1

The American College of Critical Care Medicine recommends transfusing PRBCs when hemoglobin falls below 7 g/dL in hemodynamically stable patients, including critically ill patients requiring mechanical ventilation and resuscitated trauma patients 4, 5, 6
Consider transfusion at hemoglobin 8 g/dL or below in patients with preexisting cardiovascular disease or symptoms of inadequate tissue oxygenation, as recommended by the American Heart Association 5, 7, 6
The decision to transfuse should incorporate clinical symptoms and biochemical markers, not hemoglobin level alone, according to the American College of Physicians 4, 5, 8

Order PRBCs one unit at a time and reassess clinically after each unit before deciding whether additional transfusion is needed, as recommended by the American College of Critical Care Medicine 4, 3
PRBCs must be crossmatched for ABO compatibility before transfusion, according to the American Association of Blood Banks 3

Cancer patients with chemotherapy-induced anemia: PRBCs provide the only option for immediate correction when rapid hemoglobin increase is needed, as recommended by the National Comprehensive Cancer Network 1, 2
Critically ill patients: a restrictive strategy (transfusion trigger <7 g/dL) is as effective as liberal strategy (trigger <10 g/dL) and avoids unnecessary transfusion risks, according to the American College of Critical Care Medicine 4
Cardiac disease patients: higher thresholds (7-8 g/dL) may be appropriate, but liberal transfusion strategies show no benefit, as recommended by the American Heart Association 4, 5, 7

PRBCs carry risks including venous thromboembolism, arterial thromboembolism, and increased mortality in cancer patients, according to the National Comprehensive Cancer Network 1, 9, 3
Transfusion-related acute lung injury and transfusion-associated circulatory overload remain important complications requiring vigilance, as recommended by the American College of Critical Care Medicine and the American Thoracic Society 4, 5
Febrile nonhemolytic reactions are the most common adverse event, though leukoreduction has significantly reduced their incidence, according to the American Association of Blood Banks 1

Do not transfuse based solely on a hemoglobin threshold—always assess the patient's symptoms, comorbidities, volume status, and evidence of tissue hypoxia, as recommended by the American College of Physicians and the American College of Critical Care Medicine 4, 5, 6, 8
Avoid ordering multiple units simultaneously—transfuse one unit at a time with clinical reassessment to prevent overtransfusion, according to the American College of Critical Care Medicine and the American Association of Blood Banks 4, 3